MRTX1133 is a potent, selective, and non-covalent small-molecule inhibitor targeting the KRAS G12D mutant with sub-picomolar affinity (K_D = 0.2 pM). It demonstrates antitumor efficacy in G12D-mutated cell lines and in vivo models, showing selectivity over wild-type KRAS, making it a valuable research tool for oncology and targeted therapy studies.
Molekulargewicht:
600.63
Reinheit:
99.60% (May vary between batches)
CAS Nummer:
[2621928-55-8]
Formel:
C33H31F3N6O2
Target-Kategorie:
Kras,Ras
Anwendungsbeschreibung:
Solubility: DMSO: 50 mg/mL (83.25 mM), Sonication is recommended
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten